The rapid development of techniques in molecular biology over the past 20 years has ushered in a new era in microbiology and infectious diseases. The development of these powerful new methods has already had a profound impact in the clinical microbiology laboratory and in research on the molecular epidemiology and pathogenesis of infectious diseases. The breadth of these advances will continue to expand at an even greater rate as new tools are applied to the study of old problems as well as to the study ofthe ever increasing number of emerging infectious diseases.
Introduction
The rapid development of techniques in molecular biology over the past 20 years has ushered in a new era in microbiology and infectious diseases. The development of these powerful new methods has already had a profound impact in the clinical microbiology laboratory and in research on the molecular epidemiology and pathogenesis of infectious diseases. The breadth of these advances will continue to expand at an even greater rate as new tools are applied to the study of old problems as well as to the study ofthe ever increasing number of emerging infectious diseases.
The purpose of this review is to present an overview of some of the applications of molecular techniques to the study of human bacterial pathogens. Rather than dealing with details of methodology, this review will focus on the impact of new technology on clinical applications and research in the diagnosis, epidemiology and pathogenesis of infectious diseases. While the main focus will be human bacterial pathogens, it should be noted that the study of all microbes has been affected by application of new approaches. The selected examples which are discussed below do not represent an exhaustive list but illustrate important areas in which the use of molecular tools has been most productive.
Diagnosis of bacterial infections
For the past 100 years, the laboratory diagnosis of infectious diseases has relied on direct methods such as bacterial culture. These well described techniques can be used in most clinical laboratories. More recently, immunoassays such as immunofluorescence, immunoblot and enzyme linked immunosorbent assay have become useful adjuncts in the clinical laboratory. These techniques, usually used in the setting of large tertiary health care centres, facilitate the aetiological diagnosis of infectious diseases in many situations.
ADVANTAGES OF MOLECULAR BASED TECHNIQUES
There are two significant limitations to the above mentioned methods. Firstly, culture techniques are limited because some pathogens require a lengthy period of time to be identified, exhibit similar characteristics to non-pathogenic species, thereby necessitating specialised testing, or have fastidious growth requirements making detection by culture difficult. Secondly, the newer immunoassays are generally labour intensive or require expensive equipment, or both. These two factors account for difficulty in applying these diagnostic methods in smaller hospitals, clinics, less developed countries, or to the field."2 Time is a crucial variable in any diagnostic test, irrespective of the centre at which it is performed. Timely determination of the specific aetiological agent of an infectious process is critical. Rapid, accurate diagnosis of aetiology will improve the quality of health care and reduce health care costs in several ways: (1) earlier institution of appropriate therapy will reduce infection related morbidity and mortality; (2) PCR is most likely to supplant current methods in situations in which the diagnosis relies on cultures of microbes with fastidious growth requirements (for example, Bordetella pertussis, Borrelia burgdorferi, Pneumocystis cariniz), when culturing is dangerous (Bacillus anthracis, HIV, Lassa fever), the organism grows slowly (Mycobacteria),'67 or the culture method is not sensitive enough to detect the pathogen in the clinical sample (herpes simplex virus in spinal fluid).8 PCR technology has great potential for screening a single clinical sample, such as spinal fluid, a swab from a genital ulcer, or sputum69 for multiple potential pathogens. For example, a sputum sample or bronchoalveolar lavage fluid from a patient with pneumonia could be screened for various bacteria, fungi and viruses which are most likely to be the aetiological agent of pulmonary infection. Quantitative PCR can also be used to follow a therapeutic response to treatment of infections such as malaria, tuberculosis, HIV, and hepatitis C.2'6 PCR has become the method of choice for the laboratory diagnosis of HIV infection in neonates and infants. 1' In some clinical settings the type of organism present may not be known. Ribosomal RNA probes have proved to be useful in the detection of bacterial DNA. Oligonucleotide probes based on shared 16S rRNA sequences among all bacterial species (eubacterial primers) have been developed. These are amplified by PCR in a sample. The nucleotide sequence of the amplified DNA can be used to determine the identity of the agent in the sample. This technique has been successfully used to discover new pathogens, such as those causing Whipple's disease, cat-scratch fever, and human Ehrlichiosis.8" 12 As our understanding of genetics improves, one can envisage an algorithm of PCR and a battery of primers based on these types of shared sequences.
Another area in which PCR techniques will be used diagnostically is in the determination of resistance to available anti-infective drug therapies. The application of these techniques will greatly enhance our ability to treat patients effectively early in the course of their illness. A major impediment to the current widespread use of molecular biological techniques to deter- Typability is the proportion of strains which can be typed by a particular typing method. Phenotypic methods depend on growth of the pathogen in vitro and expression of a particular characteristic. Thus, fastidious pathogens or A DNA fingerprint is developed by each of these methods. This DNA fingerprint differs among strains because of polymorphism-that is, length differences. Agarose gel electrophoresis permits size fractionation of the DNA and detection of this polymorphism. The agarose gel can be stained and the banding pattern of DNA studied directly. ' Alternatively, the DNA can be transferred to a nylon membrane and hybridised with DNA probes of specific sequences. 19 20 In the next section, two of these methods as they have been applied to mucosal Gram negative bacterial pathogens will be discussed. The PCR based methods do not have these disadvantages but are prone to contamination and need strict quality controls. Of the two groups of methods, the PCR based methods are more promising for application in clinical microbiology laboratories. Cost effectiveness of these methods in a clinical setting needs to be addressed.
Pathogenesis
The application of molecular approaches to the study of bacterial infections has advanced the understanding of mechanisms of pathogenesis over the past decade. The ability to characterise the molecular interaction between host and pathogen is critical for understanding pathogenesis so that better methods of prevention and treatment can be designed.
ADHERENCE OF BACTERIAL PATHOGENS TO HOST CELLS
The initial step in the pathogenesis of bacterial infections is often colonisation of a mucosal surface. In order for colonisation to occur molecules on the bacterial cell surface (adhesins) must bind to molecules on the epithelial cell surface (receptors). This adhesin-receptor interaction partly accounts for the host and organ specificity of bacterial infection. For example, bacterial species which are exclusively human pathogens (for example, Neisseria gonorrhoeae, H influenzae, B catarrhalis) may derive their host specificity from the interaction of adhesin molecules with receptors which are unique to human epithelial cells. Adhesinreceptor interactions probably partly account for tissue specificity as well. Respiratory tract pathogens express adhesins which bind receptors on epithelial cells ofthe respiratory tract whereas genitourinary tract pathogens express adhesins which bind receptors on urogenital epithelial cells. Elucidating the mechanisms and specificity of these molecular interactions is important for understanding the pathogenesis of bacterial infection. An understanding ofthe molecular architecture of Gram negative outer membrane proteins has had an important influence on approaches to the study of pathogenesis of infections caused by these organisms. A variety of molecular approaches has been applied for studying the antigenic structure of outer membrane proteins. These include the development of monoclonal antibodies, cloning outer membrane protein genes, sequence determination and analysis, recombinant expression of selected regions ofprotein molecules, mutagenesis studies, and others. An understanding of molecular structure of surface molecules is also essential. For example, investigators have been studying the role of NTHI in lower respiratory tract infection in adults with chronic bronchitis for decades.2' A serological approach has been used to evaluate a potential role of NTHI in these infections. The development of an antibody response to the putative pathogen has been accepted as evidence that the organism causes the disease. Several studies from different centres have used this approach. Some studies showed no antibody response, some studies showed higher titres of antibodies in patients compared with controls but no correlation with clinical exacerbations, and some studies showed an antibody response to NTHI following infection (reviewed in 21). These apparently conflicting results defied explanation until more was known about the antigenic structure of the outer membrane of this bacterium.
The molecular architecture of the P2 porin protein of NTHI accounts for the apparently conflicting results of serological studies in patients with chronic bronchitis. P2 is the most abundant protein in the outer membrane and contains an immunodominant, strain specific epitope."" Preliminary studies indicate that the predominant immune response to NTHI is directed against this strain specific immunodominant epitope. 34 The host is thereby protected from infection by the same strain but remains susceptible to infection by other strains of the species. Therefore, serological studies which used laboratory strains of NTHI rather than the patient's homologous strain failed to detect the predominant immune response. Furthermore, an understanding of the antigenic structure of the major outer membrane proteins and the host immune response to specific epitopes on these outer membrane proteins allows one to explain why adults with chronic bronchitis experience recurrent infections by the same bacterial species in spite of having an intact immune system.
Over the past decade much has been learned about the outer membrane structure of Gram negative bacteria. This work has led to the identification of a common theme in the molecular structure of porin molecules.35-37 These protein molecules consist of a P pleated sheet with 16 strands that traverse and remain largely buried within the outer membrane. Interspersed within the relatively conserved backbone of the protein are eight peptide loops that are potentially exposed on the bacterial surface. These surface accessible loops show antigenic diversity among strains of a species. This structure has important implications for the understanding of the pathogenesis of recurrent infections. As the surface exposed loops of the major porin protein show antigenic heterogeneity among strains, an immune response to this part of the molecule will be relatively strain specific.
These two examples (molecular mechanisms of adherence and molecular structure of outer membrane proteins) are just two of numerous observations in which molecular approaches have enabled observations regarding pathogenesis of bacterial infections to be made. Studies of the molecular mechanisms of bacterial pathogenesis promises to be a productive area of investigation. The elucidation of these mechanisms will lead directly to the development of new therapeutic and prophylactic modalities for a variety of bacterial infections.
Summary
The rapid progress in the development of powerful techniques in molecular biology over the past 20 years has had an enormous impact on the disciplines of infectious diseases and microbiology. Our understanding of human bacterial pathogens has undergone significant advances, particularly in diagnosis, epidemiology and pathogenesis. Nucleic acid probes and amplification by PCR have forever changed the laboratory diagnosis of many bacterial infections by providing specific, accurate and rapid means to identify DNA from pathogens in clinical samples. The application of molecular techniques has led to the development of typing systems based on the genetic structure of bacterial pathogens. This has provided investigators with highly effective tools for studying epidemiology, transmission, evolutionary relations, and pathogenesis of bacterial pathogens. The ability to isolate and manipulate bacterial genes has resulted in a virtual explosion of new information on molecular mechanisms of bacterial pathogenesis. These important advances in diagnosis, epidemiology and pathogenesis will lead directly to better means of treatment and prevention of a variety of bacterial infections in the next decade.
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